MassMutual Private Wealth & Trust’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$862 Sell
10
-15
-60% -$1.35K ﹤0.01% 2122
2026
Q2
$2.39K Buy
25
+13
+108% +$1.18K ﹤0.01% 1952
2026
Q1
$1.16K Sell
12
-2
-14% -$200 ﹤0.01% 2106
2025
Q4
$1.36K Sell
14
-1
-7% -$86 ﹤0.01% 2085
2025
Q3
$1.07K Buy
15
+6
+67% +$400 ﹤0.01% 2133
2025
Q2
$538 Hold
9
– – ﹤0.01% 2216
2025
Q1
$472 Hold
9
– – ﹤0.01% 2237
2024
Q4
$495 Hold
9
– – ﹤0.01% 2142
2024
Q3
$453 Hold
9
– – ﹤0.01% 1988
2024
Q2
$395 Hold
9
– – ﹤0.01% 1988
2024
Q1
$396 Hold
9
– – ﹤0.01% 1898
2023
Q4
$427 Hold
9
– – ﹤0.01% 1839
2023
Q3
$399 Hold
9
– – ﹤0.01% 1862
2023
Q2
$430 Hold
9
– – ﹤0.01% 1801
2023
Q1
$354 Hold
9
– – ﹤0.01% 1729
2022
Q4
$0 Buy
+9
New +$257 ﹤0.01% 1739

Other funds holding IRMD

MassMutual Private Wealth & Trust's IRMD Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its iRadimed (IRMD) stake by 60% in Q3 2026, selling an estimated $1.35K and leaving 10 shares worth $862. The position accounts for ﹤0.01% of the portfolio, ranked #2122.

MassMutual Private Wealth & Trust first reported a position in IRMD in Q4 2022 and has held it in 16 quarters since. The position peaked at $2.39K in Q2 2026. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • MassMutual Private Wealth & Trust held 10 shares of iRadimed worth $862 as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 15 iRadimed shares in Q3 2026, an estimated $1.35K.
  • iRadimed made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #2122 holding.
  • MassMutual Private Wealth & Trust first reported a position in iRadimed in Q4 2022 and has held it in 16 quarters since.
  • MassMutual Private Wealth & Trust's iRadimed position peaked at $2.39K in Q2 2026.
  • 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.